August 9, 2024. Leonide Saad, PhD, founder and chief scientific officer of the biotech Alkeus, talks to host Ben Shaberman about his company’s emerging therapy, gildeuretinol, a modified form of vitamin A which has performed well in clinical trials for people with Stargardt disease.
This episode of the Eye on the Cure Podcast is sponsored by Alkeus Pharmaceuticals.
